United States

Mitsubishi Chemical Holdings Corp (4188.T)

4188.T on Tokyo Stock Exchange

16 Nov 2018
Change (% chg)

¥-12 (-1.25%)
Prev Close
Day's High
Day's Low
Avg. Vol
52-wk High
52-wk Low

Latest Key Developments (Source: Significant Developments)

Ube Industries, JSR and Mitsubishi Chemical announce start of new company for integration of ABS resin business
Tuesday, 9 Jan 2018 01:35am EST 

Jan 9 (Reuters) - JSR Corp <4185.T>:Says it will start to set up a Tokyo-based company on April 1, for integration of ABS resin business, with UMG ABS, Ltd., which is equally owned by Ube Industries Ltd <<<4208.T>>> (50 percent) and Mitsubishi Chemical Corp (50 percent).Says the new company will be capitalized at 3 billion yen .Says it will hold 51 percent stake in the new company after transaction .  Full Article

Mitsubishi Tanabe Pharma updates license agreement with Kolon Life Secience on Invossa
Wednesday, 20 Dec 2017 02:42am EST 

Dec 20 (Reuters) - Mitsubishi Tanabe Pharma Corp <4508.T>:Says it notified Kolon Life Secience, Inc. (KLS) that the co seeks to cancel the license agreement between the co and KLS for Invossa, a cell therapy product for improvement of knee osteoarthritis symptoms .Says it has started negotiation with KLS regarding the cancellation of the License Agreement .  Full Article

Mitsubishi Chemical Unit Plans To Restart U.K. Plant - Nikkei‍​
Monday, 27 Nov 2017 04:31pm EST 


Mitsubishi Tanabe Pharma completes purchase of NeuroDerm
Wednesday, 18 Oct 2017 05:43am EDT 

Oct 18(Reuters) - Mitsubishi Tanabe Pharma Corp <4508.T>:Says it completed purchase of NeuroDerm Ltd <<>>.Purchase plan was announced on July 24.  Full Article

Mitsubishi Tanabe Pharma sells drug sales unit
Monday, 2 Oct 2017 04:17am EDT 

Oct 2(Reuters) - Mitsubishi Tanabe Pharma Corp <4508.T>:Says it sold 100 percent stake in a drug sales unit to Nipro, on Oct. 1.Previous plan was announced on March 28.  Full Article

Mitsubishi Chemical's operating profit apparently grew 30 pct for April-June quarter - Nikkei
Friday, 28 Jul 2017 01:20pm EDT 

July 28 (Reuters) - Nikkei::Mitsubishi Chemical Holdings Corp's operating profit apparently grew 30% to almost 90 billion yen for the April-June quarter - Nikkei.Mitsubishi Chemical Holdings Corp's sales revenue likely climbed 9% to about 900 billion yen for the April-June quarter - Nikkei.  Full Article

Mitsubishi Chemical Holdings consolidated subsidiary to buy NeuroDerm for about $1.1 bln
Monday, 24 Jul 2017 02:26am EDT 

July 24(Reuters) - Mitsubishi Chemical Holdings Corp <4188.T>:Says its consolidated subsidiary Mitsubishi Tanabe Pharma Corp <<<4508.T>>> will buy NeuroDerm Ltd <<>>, for about $1.1 billion (about 124.1 billion yen), $39 per share, effective October .  Full Article

Jingdong Group to start a vegetable factory in tie-up with Mitsubishi Chemical Holdings - Nikkei
Tuesday, 20 Jun 2017 12:14pm EDT 

June 20 (Reuters) - Nikkei::Jingdong will start a vegetable factory in the Tongzhou district of Beijing under a partnership deal with Mitsubishi Chemical Holdings - Nikkei.Jingdong's vegetable factory, costing about 800 million yen, will be supplied by Mitsubishi Chemical, and is slated to open by next spring - Nikkei.  Full Article

R&I affirms Mitsubishi Tanabe Pharma's rating at "A+" and announces stable outlook-R&I
Monday, 12 Jun 2017 02:09am EDT 

June 12 (Reuters) - Mitsubishi Tanabe Pharma Corp <4508.T>:Says Rating and Investment Information, Inc. (R&I) affirmed the company's rating at "A+" -R&I.Says rating outlook stable -R&I.  Full Article

Mitsubishi Chemical Holdings' sales for year ended in March dropped 5% on ifrs-adjusted basis -Nikkei
Tuesday, 9 May 2017 04:09pm EDT 

May 10 (Reuters) - Nikkei::Mitsubishi Chemical Holdings' core operating income seen rising 3 percent to nearly 310 billion yen for the year ended in march - Nikkei .Mitsubishi Chemical Holdings' sales for the year ended in March dropped 5% on an IFRS-adjusted basis - Nikkei .Mitsubishi Chemical Holdings' core operating income is expected to grow again in the current fiscal year through March 2018 - Nikkei.  Full Article

Fed. Circuit upholds decision canceling claims in Durezol eyedrops patent

A federal appeals court on Wednesday upheld a ruling that invalidated a patent covering Novartis AG's Durezol, opening the door for Akorn Inc to launch a generic version of the eye medication.